These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

510 related articles for article (PubMed ID: 12010861)

  • 21. Comparison of selective retinoic acid receptor- and retinoic X receptor-mediated efficacy, tolerance, and survival in cutaneous t-cell lymphoma.
    Querfeld C; Rosen ST; Guitart J; Rademaker A; Fung BB; Posten W; Kuzel TM
    J Am Acad Dermatol; 2004 Jul; 51(1):25-32. PubMed ID: 15243520
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Potential role for retinoic acid receptor-gamma in the inhibition of breast cancer cells by selective retinoids and interferons.
    Fanjul AN; Bouterfa H; Dawson M; Pfahl M
    Cancer Res; 1996 Apr; 56(7):1571-7. PubMed ID: 8603404
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vivo and microarray analysis of rexinoid-responsive anaplastic thyroid carcinoma.
    Klopper JP; Berenz A; Hays WR; Sharma V; Pugazhenthi U; Janssen J; Singh M; Bissonnette RP; Haugen BR
    Clin Cancer Res; 2008 Jan; 14(2):589-96. PubMed ID: 18223235
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The retinoid X receptor-selective ligand, LGD1069, inhibits tumor-induced angiogenesis via suppression of VEGF in human non-small cell lung cancer.
    Fu J; Ding Y; Huang D; Li H; Chen X
    Cancer Lett; 2007 Apr; 248(1):153-63. PubMed ID: 17027148
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Growth inhibition of human in vitro and mouse in vitro and in vivo mammary tumor models by retinoids in comparison with tamoxifen and the RU-486 anti-progestagen.
    Darro F; Cahen P; Vianna A; Decaestecker C; Nogaret JM; Leblond B; Chaboteaux C; Ramos C; Pétein M; Budel V; Schoofs A; Pourrias B; Kiss R
    Breast Cancer Res Treat; 1998 Sep; 51(1):39-55. PubMed ID: 9877028
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Induction of apoptosis in MCF-7 breast carcinoma cell line by RAR and RXR selective retinoids.
    Toma S; Isnardi L; Riccardi L; Bollag W
    Anticancer Res; 1998; 18(2A):935-42. PubMed ID: 9615744
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pattern of retinoid-induced teratogenic effects: possible relationship with relative selectivity for nuclear retinoid receptors RAR alpha, RAR beta, and RAR gamma.
    Elmazar MM; Reichert U; Shroot B; Nau H
    Teratology; 1996 Mar; 53(3):158-67. PubMed ID: 8761883
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A ligand of peroxisome proliferator-activated receptor gamma, retinoids, and prevention of preneoplastic mammary lesions.
    Mehta RG; Williamson E; Patel MK; Koeffler HP
    J Natl Cancer Inst; 2000 Mar; 92(5):418-23. PubMed ID: 10699072
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of VEGF receptors significantly impairs mammary cancer growth in C3(1)/Tag transgenic mice through antiangiogenic and non-antiangiogenic mechanisms.
    Huh JI; Calvo A; Stafford J; Cheung M; Kumar R; Philp D; Kleinman HK; Green JE
    Oncogene; 2005 Jan; 24(5):790-800. PubMed ID: 15592523
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multiple factors contribute to the toxicity of the aromatic retinoid, TTNPB (Ro 13-7410): binding affinities and disposition.
    Pignatello MA; Kauffman FC; Levin AA
    Toxicol Appl Pharmacol; 1997 Feb; 142(2):319-27. PubMed ID: 9070355
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combination chemoprevention of HER2/neu-induced breast cancer using a cyclooxygenase-2 inhibitor and a retinoid X receptor-selective retinoid.
    Brown PH; Subbaramaiah K; Salmon AP; Baker R; Newman RA; Yang P; Zhou XK; Bissonnette RP; Dannenberg AJ; Howe LR
    Cancer Prev Res (Phila); 2008 Aug; 1(3):208-14. PubMed ID: 19138958
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synergistic effect of a retinoid X receptor-selective ligand bexarotene (LGD1069, Targretin) and paclitaxel (Taxol) in mammary carcinoma.
    Yen WC; Prudente RY; Lamph WW
    Breast Cancer Res Treat; 2004 Nov; 88(2):141-8. PubMed ID: 15564797
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multiple factors contribute to the toxicity of the aromatic retinoid TTNPB (Ro 13-7410): interactions with the retinoic acid receptors.
    Pignatello MA; Kauffman FC; Levin AA
    Toxicol Appl Pharmacol; 1999 Sep; 159(2):109-16. PubMed ID: 10495774
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lack of efficacy of the statins atorvastatin and lovastatin in rodent mammary carcinogenesis.
    Lubet RA; Boring D; Steele VE; Ruppert JM; Juliana MM; Grubbs CJ
    Cancer Prev Res (Phila); 2009 Feb; 2(2):161-7. PubMed ID: 19196723
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Marked improvement induced in photoaged skin of hairless mouse by ER36009, a novel RARgamma-specific retinoid, but not by ER35794, an RXR-selective agonist.
    Sakuta T; Kanayama T
    Int J Dermatol; 2006 Nov; 45(11):1288-95. PubMed ID: 17076708
    [TBL] [Abstract][Full Text] [Related]  

  • 36. LAS, a novel selective estrogen receptor modulator with chemopreventive and therapeutic activity in the N-nitroso-N-methylurea-induced rat mammary tumor model.
    Cohen LA; Pittman B; Wang CX; Aliaga C; Yu L; Moyer JD
    Cancer Res; 2001 Dec; 61(24):8683-8. PubMed ID: 11751385
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Short-term modulation of cell proliferation and apoptosis and preventive/therapeutic efficacy of various agents in a mammary cancer model.
    Christov K; Grubbs CJ; Shilkaitis A; Juliana MM; Lubet RA
    Clin Cancer Res; 2007 Sep; 13(18 Pt 1):5488-96. PubMed ID: 17875779
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Retinoids suppress premalignant MCF10AT but not malignant MCF10CA1a breast epithelial cells in vivo. Role of retinoic acid receptor beta2 expression.
    Peng X; Wood S; Bratescu L; Shilkaitis A; Christov K
    Cancer Lett; 2005 May; 222(2):153-63. PubMed ID: 15863264
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Induction of PDCD4 tumor suppressor gene expression by RAR agonists, antiestrogen and HER-2/neu antagonist in breast cancer cells. Evidence for a role in apoptosis.
    Afonja O; Juste D; Das S; Matsuhashi S; Samuels HH
    Oncogene; 2004 Oct; 23(49):8135-45. PubMed ID: 15361828
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of effective retinoids for inhibiting growth and inducing apoptosis in bladder cancer cells.
    Zou C; Liebert M; Zou C; Grossman HB; Lotan R
    J Urol; 2001 Mar; 165(3):986-92. PubMed ID: 11176527
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.